(Q38234432)

31 August 2017

0 references

Diabetes mellitus is associated with elevated risk of mortality amongst patients with prostate cancer: a meta-analysis of 11 cohort studies (English)

1 reference

31 August 2017

1 reference

1 reference

Hongzhou Cai

1

1 reference

31 August 2017

Zicheng Xu

2

1 reference

31 August 2017

Ting Xu

3

1 reference

31 August 2017

Bin Yu

4

1 reference

31 August 2017

Qing Zou

5

1 reference

31 August 2017

language of work or name

1 reference

14 September 2014

1 reference

Diabetes - Metabolism: Research and Reviews

31 August 2017

1 reference

31 August 2017

31

1 reference

31 August 2017

4

1 reference

31 August 2017

336-343

1 reference

Global estimates of the prevalence of diabetes for 2010 and 2030

31 August 2017

1 reference

Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study

21 January 2018

1 reference

Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies

21 January 2018

1 reference

Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer?

21 January 2018

1 reference

Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study

21 January 2018

1 reference

21 January 2018

Cancer statistics, 2010

1 reference

Global cancer statistics, 2002

21 January 2018

1 reference

Diabetes mellitus and risk of prostate cancer: an updated meta-analysis based on 12 case-control and 25 cohort studies.

21 January 2018

1 reference

Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis

21 January 2018

1 reference

Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study.

21 January 2018

1 reference

Preoperative cardiopulmonary risk assessment as predictor of early noncancer and overall mortality after radical prostatectomy

21 January 2018

1 reference

Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02.

21 January 2018

1 reference

Modifiable risk factors for prostate cancer mortality in London: forty years of follow-up in the Whitehall study

21 January 2018

1 reference

Type 2 diabetes and the risk of mortality among patients with prostate cancer

21 January 2018

1 reference

Does pre-existing diabetes affect prostate cancer prognosis? A systematic review.

21 January 2018

1 reference

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

Quantitative synthesis in systematic reviews

21 January 2018

1 reference

Meta-analysis in clinical trials

21 January 2018

1 reference

Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival

21 January 2018

1 reference

A prospective study of the associations between treated diabetes and cancer outcomes

21 January 2018

1 reference

Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis

21 January 2018

1 reference

Primary Gleason pattern does not impact survival after permanent interstitial brachytherapy for Gleason score 7 prostate cancer

21 January 2018

1 reference

Type 2 diabetes: a protective factor for prostate cancer? An overview of proposed mechanisms

21 January 2018

1 reference

Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts

21 January 2018

1 reference

Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis

21 January 2018

1 reference

Androgen and prostate cancer: is the hypothesis dead?

21 January 2018

1 reference

Low testosterone levels are common and associated with insulin resistance in men with diabetes.

21 January 2018

1 reference

Prospective study of sex hormone levels and risk of prostate cancer

21 January 2018

1 reference

Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and Nutrition

21 January 2018

1 reference

Therapy insight: Influence of type 2 diabetes on the development, treatment and outcomes of cancer

21 January 2018

1 reference

Obesity, Diabetes, and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial

21 January 2018

1 reference

A meta-analysis of diabetes mellitus and the risk of prostate cancer

21 January 2018

1 reference

7 January 2021

Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies.

1 reference

7 January 2021

The development and validation of a comorbidity index for prostate cancer among Black men

1 reference

7 January 2021

The impact of type 2 diabetes mellitus on cancer-specific survival: a follow-up study in Sweden

1 reference

7 January 2021

The impact of diabetes mellitus on survival in men with clinically localized prostate cancer treated with permanent interstitial brachytherapy

1 reference

7 January 2021

Causes of death in men with prevalent diabetes and newly diagnosed high- versus favorable-risk prostate cancer

1 reference

7 January 2021

Insulin Increases De Novo Steroidogenesis in Prostate Cancer Cells

1 reference

7 January 2021

Increased serum insulin associated with increased risk of prostate cancer recurrence

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.2582

1 reference

31 August 2017

1 reference